<DOC>
	<DOCNO>NCT01275651</DOCNO>
	<brief_summary>This research trial study biomarkers bone marrow blood sample patient prostate cancer treat ketoconazole . Studying sample bone marrow blood patient prostate cancer laboratory may help doctor learn change occur deoxyribonucleic acid ( DNA ) identify biomarkers related cancer .</brief_summary>
	<brief_title>Biomarkers Bone Marrow Blood Samples From Patients With Prostate Cancer Treated With Ketoconazole</brief_title>
	<detailed_description>PRIMARY OBJECTIVES : I . To determine whether pre-treatment androgen receptor ( AR ) activity correlate progression-free survival ( PFS ) men castration-resistant prostate cancer ( CRPC ) treat ketoconazole . SECONDARY OBJECTIVES : I . To determine expression androgen transport/synthesis/metabolism gene ( include cytochrome P450 , family 17 , subfamily A , polypeptide 1 [ CYP17A1 ] , aldo-keto reductase family 1 [ AKR1 ] C3 , hydroxy-delta-5-steroid dehydrogenase , 3 beta- steroid delta-isomerase 2 [ HSD3B2 ] , hydroxysteroid [ 17-beta ] dehydrogenase [ HSD17B ] 3 , HSD17B6 , AKR1C2 , AKR1C1 , UGTB15 , UGTB17 , steroid-5-alpha-reductase , alpha polypeptide 1 [ 3-oxo-5 alpha-steroid delta 4-dehydrogenase alpha ] [ SRD5A ] 1 , SRD5A2 , SRD5A3 , solute carrier organic anion transporter family , member 2B1 [ SLCO2B1 ] ) correlate detect AR activity , time progression ( progression free survival [ PFS ] ) follow treatment ketoconazole , overall survival . II . To determine semi-quantitative immunohistochemical analysis AR AKR1C3 protein level correlate PFS follow treatment ketoconazole . III . To determine specific AR splice variation correlate PFS response ketoconazole . IV . To determine detected activity signal pathway interact AR pathway activity ( e.g. , phosphatidylinositol-4,5-bisphosphate 3-kinase , catalytic subunit alpha [ PI3K ] downstream effector , SRC proto-oncogene , non-receptor tyrosine kinase [ SRC ] , others ) correlate detect AR activity , PFS , OS . V. To determine AR gene amplification correlate detect AR activity PFS ketoconazole . VI . To determine level testosterone dihydrotestosterone ( DHT ) tumor tissue correlate AR activity PFS ketoconazole . VII . To determine presence specific prostate cancer-associated gene translocation sample CRPC . VIII . To provide unbiased data set gene expression CRPC markedly expand currently available public domain data . IX . To provide library amplified ribonucleic acid ( RNA ) complementary ( c ) DNA analysis investigator . OUTLINE : Previously collect bone marrow , tissue , blood sample analyze AR activity , AR splice variation , expression androgen transport/synthesis/metabolism gene , AKR1C3 protein level , testosterone dihydrotestosterone level via reverse transcription ( RT ) -polymerase chain reaction ( PCR ) , single nucleotide polymorphism ( SNP ) microarrays , immunohistochemistry ( IHC ) , gene expression analysis , mass spectrometry method .</detailed_description>
	<mesh_term>Prostatic Neoplasms</mesh_term>
	<mesh_term>Ketoconazole</mesh_term>
	<criteria>Inclusioin Criteria : Patients must register CALGB 9583 CALGB 9663 Adequate tissue specimen available analysis</criteria>
	<gender>Male</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>July 2016</verification_date>
	<keyword>adenocarcinoma prostate</keyword>
	<keyword>recurrent prostate cancer</keyword>
</DOC>